Myrbetriq (mirabegron) – sold as Betanis and Betmiga in some markets – is an extended-release selective β3-adrenoceptor agonist therapy used to treat overactive bladder with symptoms of ...

Negio Therapeutics NV has divulged guanfacine derivatives acting as α2-adrenoceptor agonists reported to be useful for the treatment of cancer. α-Adrenoceptor agonists disclosed in Negio patents | ...

Objective To evaluate nyctohemeral effects of topical beta-adrenoceptor blocking agents and their fixed combinations on intraocular pressure (IOP) in patients with primary open-angle glaucoma ...

Cardiologists are faced with two clinical scenarios. The first is the elevated norepinephrine, whose actions must be properly counteracted by adrenoceptor blockade to avoid catastrophic consequences.

This fundamental study explores a novel cellular mechanism underlying the degeneration of locus coeruleus neurons during chronic restraint stress. The evidence supporting the overexpression of LC ...

Preventive antimigraine therapy (PAM) should probably not be considered until the headache frequency exceeds 1 per week. PAM is associated with significant side effects and often with ...

Neuroinflammation and oxidative stress are pivotal contributors to neurodegenerative and psychiatric disorders. Two studies exemplify how novel compounds can mitigate these processes. Hou et al.